These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36552947)

  • 1. Interplay between Myokine Profile and Glycemic Control in Type 2 Diabetes Mellitus Patients with Heart Failure.
    Berezin AA; Obradovic Z; Novikov EV; Boxhammer E; Lichtenauer M; Berezin AE
    Diagnostics (Basel); 2022 Nov; 12(12):. PubMed ID: 36552947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Kidney Function Outcomes and Their Relation to SGLT2 Inhibitor Dapagliflozin in Patients with Type 2 Diabetes Mellitus Who Had Chronic Heart Failure.
    Berezina TA; Fushtey IM; Berezin AA; Pavlov SV; Berezin AE
    Adv Ther; 2024 Jan; 41(1):292-314. PubMed ID: 37935870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Circulating MicroRNAs and Myokines and Interactions with Serum Osteopontin in Type 2 Diabetic Patients with Moderate and Poor Glycemic Control: A Biochemical and Molecular Study.
    Al-Rawaf HA; Alghadir AH; Gabr SA
    Biomed Res Int; 2021; 2021():7453000. PubMed ID: 34917685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus.
    Berezin AA; Lichtenauer M; Boxhammer E; Fushtey IM; Berezin AE
    Front Physiol; 2022; 13():922775. PubMed ID: 35651870
    [No Abstract]   [Full Text] [Related]  

  • 5. Discriminative Value of Serum Irisin in Prediction of Heart Failure with Different Phenotypes among Patients with Type 2 Diabetes Mellitus.
    Berezin AA; Lichtenauer M; Boxhammer E; Stöhr E; Berezin AE
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adropin Predicts Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure.
    Berezina TA; Obradovic Z; Boxhammer E; Berezin AA; Lichtenauer M; Berezin AE
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure.
    Berezin AA; Obradovic Z; Fushtey IM; Berezina TA; Novikov EV; Schmidbauer L; Lichtenauer M; Berezin AE
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36830993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of serum irisin for chronic heart failure in patients with type 2 diabetes mellitus.
    Berezin AA; Fushtey IM; Pavlov SV; Berezin AE
    Mol Biomed; 2022 Nov; 3(1):34. PubMed ID: 36350412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients.
    Berezin AA; Fushtey IM; Berezin AE
    J Cardiovasc Dev Dis; 2022 Jan; 9(1):. PubMed ID: 35050233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irisin is a predictor of sarcopenic obesity in type 2 diabetes mellitus: A cross-sectional study.
    Oguz A; Sahin M; Tuzun D; Kurutas EB; Ulgen C; Bozkus O; Gul K
    Medicine (Baltimore); 2021 Jul; 100(26):e26529. PubMed ID: 34190188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower irisin level in patients with type 2 diabetes mellitus: A case-control study and meta-analysis.
    Zhang C; Ding Z; Lv G; Li J; Zhou P; Zhang J
    J Diabetes; 2016 Jan; 8(1):56-62. PubMed ID: 25494632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between myostatin and irisin in type 2 diabetes mellitus: a compensatory mechanism to an unfavourable metabolic state?
    García-Fontana B; Reyes-García R; Morales-Santana S; Ávila-Rubio V; Muñoz-Garach A; Rozas-Moreno P; Muñoz-Torres M
    Endocrine; 2016 Apr; 52(1):54-62. PubMed ID: 26438394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Sitagliptin on Serum Irisin Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus.
    Wang Q; Ma L; Zhang Y; Zhang L; An Y; Liu J; Wang G
    Diabetes Ther; 2021 Apr; 12(4):1029-1039. PubMed ID: 33625721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction.
    Lin SN; Phang KK; Toh SH; Chee KH; Zaman Huri H
    Front Endocrinol (Lausanne); 2020; 11():448. PubMed ID: 32754118
    [No Abstract]   [Full Text] [Related]  

  • 15. The Association of Serum Irisin with Bone Mineral Density and Turnover Markers in New-Onset Type 2 Diabetic Patients.
    Wang X; Hu T; Ruan Y; Yao J; Shen H; Xu Y; Zheng B; Zhang Z; Wang J; Tan Q
    Int J Endocrinol; 2022; 2022():7808393. PubMed ID: 35265126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adropin and irisin: New biomarkers of cardiac status in patients with end-stage renal disease? A preliminary study.
    Kałużna M; Pawlaczyk K; Schwermer K; Hoppe K; Człapka-Matyasik M; Ibrahim AY; Sawicka-Gutaj N; Minczykowski A; Ziemnicka K; Oko A; Ruchała M
    Adv Clin Exp Med; 2019 Mar; 28(3):347-353. PubMed ID: 30525316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between brachial-ankle pulse wave velocity and glycemic control of type 2 diabetes mellitus patients in Beijing community population].
    Sun KX; Liu ZK; Cao YY; Juan J; Xiang X; Yang C; Huang SP; Liu XF; Li N; Tang X; Li J; Wu T; Chen DF; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Jun; 47(3):431-6. PubMed ID: 26080871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification.
    Lawson CA; Jones PW; Teece L; Dunbar SB; Seferovic PM; Khunti K; Mamas M; Kadam UT
    JACC Heart Fail; 2018 Jan; 6(1):18-26. PubMed ID: 29032131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
    Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HbA1c level is associated with the development of heart failure with recovered ejection fraction in hospitalized heart failure patients with type 2 diabetes.
    Yang CD; Aihemaiti M; Quan JW; Chen JW; Shu XY; Ding FH; Shen WF; Lu L; Zhang RY; Pan WQ; Wang XQ
    Int J Cardiol; 2023 Jan; 371():259-265. PubMed ID: 36116615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.